Cargando…
The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease
Endometrial cancer (EC) is a hormone-dependent cancer that currently represents the most frequent malignancy of the female reproductive tract. The involvement of steroid hormones in EC etiology and progression has been reported. More recently, gonadotropins, and, in particular LH/hCG, are emerging a...
Autores principales: | Arcangeli, A., Noci, I., Fortunato, A., Scarselli, G. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913851/ https://www.ncbi.nlm.nih.gov/pubmed/20706654 http://dx.doi.org/10.1155/2010/486164 |
Ejemplares similares
-
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer
por: Noci, Ivo, et al.
Publicado: (2016) -
Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor’s Extracellular Hinge Region
por: Grzesik, Paul, et al.
Publicado: (2015) -
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model
por: Pillozzi, Serena, et al.
Publicado: (2013) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome
por: Plöckinger, Ursula, et al.
Publicado: (2017)